LifeMine Begins Phase 1 Trial of LIFE-001 for Immune Disorders
08 Apr 2025 //
BUSINESSWIRE
LifeMine Cuts Employees, Inspirna Shuts Down
31 Mar 2025 //
FIERCE BIOTECH
LifeMine Therapeutics Appoints Elliot Ehrich as CMO&EVP Translational Science
05 Dec 2022 //
BUSINESSWIRE
LifeMine Therapeutics Appoints Jennifer A. Jarrett to Board of Directors
13 Oct 2022 //
BUSINESSWIRE
LifeMine Appoints Martin Stah as CSO and Louis Plamondon as Executive VP
06 Oct 2022 //
BUSINESSWIRE
LifeMine locks down $70M `dream scenario` fungi deal with GSK
24 Mar 2022 //
FIERCEBIOTECH

Market Place
Sourcing Support